Evidence map›Paper›PMID 33122427›Full record

ArticleScience (New York, N.Y.)2020

A human tissue screen identifies a regulator of ER secretion as a brain-size determinant.

Christopher Esk, Dominik Lindenhofer, Simon Haendeler, Roelof A Wester, Florian Pflug, Benoit Schroeder, Joshua A Bagley, Ulrich Elling, Johannes Zuber, Arndt von Haeseler and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. ReducedInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Review
  17. Article
  18. Functional Neurogenomics to Dissect Disease Mechanisms Across Models.Annual review of genomics and human genetics · 2025
    Review
  19. Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Christopher Esk *Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID 0000-0003-1833-0801
Dominik Lindenhofer *Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID 0000-0001-8838-7163
Simon HaendelerInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID 0000-0003-0442-3177
Roelof A WesterInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
Florian PflugCenter for Integrative Bioinformatics Vienna (CIBIV), Max F. Perutz Laboratories, University of Vienna and Medical University of Vienna, VBC, Vienna, Austria.ORCID 0000-0002-5344-5359
Benoit SchroederCenter for Integrative Bioinformatics Vienna (CIBIV), Max F. Perutz Laboratories, University of Vienna and Medical University of Vienna, VBC, Vienna, Austria.
Joshua A BagleyInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID 0000-0002-6825-4264
Ulrich EllingInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID 0000-0002-4514-2809
Johannes ZuberResearch Institute of Molecular Pathology (IMP), VBC, Vienna, Austria.ORCID 0000-0001-8810-6835
Arndt von HaeselerCenter for Integrative Bioinformatics Vienna (CIBIV), Max F. Perutz Laboratories, University of Vienna and Medical University of Vienna, VBC, Vienna, Austria.ORCID 0000-0002-3366-4458
Jürgen A KnoblichInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), Vienna, Austria. juergen.knoblich@imba.oeaw.ac.at.ORCID 0000-0002-6751-3404
Institute of Molecular Biotechnology · ATMax Perutz Labs · ATResearch Institute of Molecular Pathology · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loss-of-function (LOF) screens provide a powerful approach to identify regulators in biological processes. Pioneered in laboratory animals, LOF screens of human genes are currently restricted to two-dimensional cell cultures, which hinders the testing of gene functions requiring tissue context. Here, we present CRISPR-lineage tracing at cellular resolution in heterogeneous tissue (CRISPR-LICHT), which enables parallel LOF studies in human cerebral organoid tissue. We used CRISPR-LICHT to test 173 microcephaly candidate genes, revealing 25 to be involved in known and uncharacterized microcephaly-associated pathways. We characterized

Indexed as

BrainCarrier ProteinsCell LineCell LineageCRISPR-Cas SystemsEndoplasmic ReticulumExtracellular Matrix ProteinsGene Knockout TechniquesGenetic TestingHumansMembrane ProteinsMicrocephalyOrganoidsOrgan SizeCarrier ProteinsExtracellular Matrix ProteinsIER3IP1 protein, humanMembrane Proteins

Identifiers

PMID33122427
OpenAlexW3094954466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.